Tardive dyskinesia
- 1 August 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 138 (8), 1261-1264
- https://doi.org/10.1001/archinte.138.8.1261
Abstract
Tardive dyskinesia is described as a severe complication of treatment with neuroleptic agents such as butyrophenones and phenothiazines in patients. Earliest manifestations are reported including dyskinesia of the tongue and oral structures. A normal extrapyramidal system physiology is presented along with a comparison of tardive dyskinesia with parkinsonism. Treatment is suggested including prevention, early diagnosis and avoidance of drugs which would exacerbate this condition.This publication has 3 references indexed in Scilit:
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Drug Therapy of Tardive DyskinesiaNew England Journal of Medicine, 1977
- Tardive Dyskinesia in Patients Treated with Major Neuroleptics: A Review of the LiteratureAmerican Journal of Psychiatry, 1968